Casdin Capital, LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 283 filers reported holding BLUEBIRD BIO INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Quarter-by-quarter ownership
Casdin Capital, LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q4 2020$39,592,000
-19.8%
915,0000.0%1.17%
-46.9%
Q3 2020$49,364,000
-26.8%
915,000
-17.2%
2.21%
-44.6%
Q2 2020$67,449,000
+32.8%
1,105,0000.0%3.99%
-26.0%
Q1 2020$50,786,000
-40.3%
1,105,000
+13.9%
5.39%
-31.1%
Q4 2019$85,118,000
-99.8%
970,000
+58.4%
7.83%
+34.5%
Q3 2019$56,239,750,000
+18.7%
612,500
+64.4%
5.82%
+31.2%
Q2 2019$47,382,000,000
+84142.2%
372,500
+4.2%
4.44%
-28.2%
Q1 2019$56,245,000
+71.8%
357,500
+8.3%
6.18%
+10.3%
Q4 2018$32,736,000
-13.1%
330,000
+27.9%
5.60%
+22.3%
Q3 2018$37,668,000
+20.0%
258,000
+29.0%
4.58%
+4.3%
Q2 2018$31,390,000
+26.8%
200,000
+37.9%
4.39%
+0.8%
Q1 2018$24,759,000
-4.1%
145,0000.0%4.35%
-30.8%
Q4 2017$25,825,000
+29.7%
145,0000.0%6.29%
+11.8%
Q3 2017$19,916,000
+191.7%
145,000
+123.1%
5.62%
+122.6%
Q2 2017$6,828,000
+194.6%
65,000
+154.9%
2.53%
+84.8%
Q1 2017$2,318,000
-54.5%
25,500
-69.1%
1.37%
-67.5%
Q4 2016$5,090,000
+25.2%
82,500
+37.5%
4.20%
+27.7%
Q3 2016$4,067,000
-23.3%
60,000
-51.0%
3.29%
-37.6%
Q2 2016$5,303,000
+4.0%
122,500
+2.1%
5.28%
-9.8%
Q1 2016$5,100,000
-33.8%
120,0000.0%5.85%
-14.0%
Q4 2015$7,706,000120,0006.81%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2019
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 1,834,965$35,066,0001.72%
Birchview Capital, LP 84,000$1,605,0001.09%
ARMISTICE CAPITAL, LLC 2,472,000$47,240,0000.80%
EcoR1 Capital, LLC 802,507$15,336,0000.53%
Parametrica Management Ltd 36,919$706,0000.53%
Bain Capital Life Sciences Investors, LLC 538,179$7,239,0000.45%
APPLETON GROUP, LLC 19,495$373,0000.32%
MANGROVE PARTNERS IM, LLC 175,587$3,355,0000.30%
Quinn Opportunity Partners LLC 230,100$4,397,0000.28%
PDT Partners, LLC 171,700$3,281,0000.24%
View complete list of BLUEBIRD BIO INC shareholders